Search Results - "Lagarde, María"
-
1
Transition times across the HIV care continuum in Spain from 2005 to 2022: a longitudinal cohort study
Published in The lancet HIV (01-07-2024)“…Ending AIDS by 2030 requires improvements across all stages of the HIV care continuum. We used a longitudinal approach to assess changes in the HIV care…”
Get full text
Journal Article -
2
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
Published in PloS one (19-05-2016)“…The aim of this study was to evaluate the frequency of transaminase elevations (TE) and total bilirubin elevations (TBE) during the first year of therapy with…”
Get full text
Journal Article -
3
Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)
Published in Clinical infectious diseases (01-01-2019)“…After 48 weeks of immunonutrition in HIV-infected individuals starting antiretroviral therapy at advanced disease, most of the T-cell, inflammation, and…”
Get full text
Journal Article -
4
Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery
Published in The Journal of infectious diseases (13-02-2021)“…Abstract Human immunodeficiency virus (HIV) infection impairs mucosal immunity and leads to bacterial translocation, fueling chronic inflammation and disease…”
Get full text
Journal Article -
5
-
6
Life expectancy of people with HIV on antiretroviral therapy in Spain
Published in AIDS (London) (01-03-2024)“…To estimate life expectancy of people with HIV (PWH) and describe causes of death. Antiretroviral therapy (ART)-naive adults from the CoRIS cohort starting ART…”
Get full text
Journal Article -
7
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial
Published in Clinical infectious diseases (15-12-2017)“…Our objective was to assess the therapeutic noninferiority of dual therapy with darunavir/ritonavir and lamivudine compared to triple therapy with…”
Get full text
Journal Article -
8
Incidence and Severity of SARS-CoV-2 Infection in HIV-Infected Individuals During the First Year of the Pandemic
Published in Journal of acquired immune deficiency syndromes (1999) (15-04-2022)“…We aim to investigate the infection rate, the clinical characteristics and outcomes of COVID-19-disease in a cohort of people living with HIV in Madrid…”
Get full text
Journal Article -
9
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study
Published in Scientific reports (03-04-2019)“…In HIV-1/HCV-coinfected patients, chronic HCV infection leads to an increased T-lymphocyte immune activation compared to HIV-monoinfected patients, thereby…”
Get full text
Journal Article -
10
-
11
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
Published in Journal of antimicrobial chemotherapy (06-11-2023)“…Abstract Objectives To evaluate the efficacy and safety of the two-pill regimen bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus…”
Get full text
Journal Article -
12
Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection
Published in European journal of clinical microbiology & infectious diseases (01-04-2019)“…Real-life cohorts have shown that the effectiveness of all-oral, direct-acting antivirals (DAA) for HCV treatment is > 90%. We aimed to explore the predictive…”
Get full text
Journal Article -
13
S3587 Minimally Invasive Diagnosis of Linitis Plastica With EUS-FNA
Published in The American journal of gastroenterology (01-10-2024)Get full text
Journal Article -
14
S4405 Ping-Pong Gaze as an Atypical Presentation of Hepatic Encephalopathy: A Case Report
Published in The American journal of gastroenterology (01-10-2024)Get full text
Journal Article -
15
Sustained virological response at week 12 after interferon-free therapy as criterion for HCV cure definition: Validation in a real-life cohort of HIV-coinfected patients
Published in Enfermedades infecciosas y microbiologia clinica (English ed.) (01-06-2020)“…Sustained virological response (SVR) 12 weeks after the end-of-therapy (EOT) has been correlated with SVR24 for HCV-monoinfection. We aim to validate SVR12 as…”
Get full text
Journal Article -
16
S4573 Cutaneous Bleeding Caput Medusa: A Life-Threatening Condition
Published in The American journal of gastroenterology (01-10-2024)Get full text
Journal Article -
17
S4574 An Unusual Case of Bleeding Varices: Hepatic Schistosomiasis
Published in The American journal of gastroenterology (01-10-2024)Get full text
Journal Article -
18
S2454 A Rare Case of Extrahepatic Paraganglioma Presenting With Biliary Obstruction in a 29-year-old man
Published in The American journal of gastroenterology (01-10-2024)Get full text
Journal Article -
19
S1855 Diagnostic Accuracy of HCV Core Antigen Testing in Hemodialysis Patients: A Systematic Review and Meta-Analysis
Published in The American journal of gastroenterology (01-10-2024)Get full text
Journal Article -
20
HCV eradication with all-oral therapy in cirrhotic HIV-coinfected patients: an observational study of early changes in liver function and fibrosis tests
Published in Revista española de enfermedades digestivas (01-08-2019)“…liver laboratory tests improve in hepatitis C virus (HCV)-monoinfected and cirrhotic patients who achieve HCV cure after interferon-free treatment. this study…”
Get full text
Journal Article